Pharmacy Usual Items - Zambia

  • Zambia
  • Revenue in the Pharmacy Usual Items market is projected to reach US$18.74m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.94%, resulting in a market volume of US$25.01m by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.89 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Zambia has been experiencing significant growth in recent years. Customer preferences have shifted towards a greater demand for over-the-counter medications and health products. This trend can be attributed to several factors, including increased awareness of health and wellness, a growing middle class, and the expansion of the healthcare sector in the country.

Customer preferences:
Zambian consumers are becoming more health-conscious and are actively seeking out products that promote their well-being. This shift in customer preferences can be seen in the increased demand for over-the-counter medications, such as pain relievers, cough and cold remedies, and vitamins and supplements. Additionally, there is a growing demand for health products, such as herbal remedies and natural supplements, as consumers are becoming more interested in alternative medicine and holistic approaches to healthcare.

Trends in the market:
One of the key trends in the Pharmacy Usual Items market in Zambia is the increasing availability and accessibility of over-the-counter medications and health products. Pharmacies are expanding their product offerings to cater to the growing demand, and new pharmacies are opening up across the country. This trend is driven by the increasing number of people seeking healthcare services and the need for convenient access to medications and health products. Another trend in the market is the growing presence of international pharmaceutical companies in Zambia. These companies are investing in the country's healthcare sector and introducing a wide range of products to meet the needs of the local population. This has led to increased competition in the market, driving innovation and offering consumers a greater variety of options.

Local special circumstances:
Zambia has a relatively young population, with a large proportion of the population under the age of 25. This demographic trend has contributed to the growing demand for over-the-counter medications and health products, as younger consumers are more likely to be proactive about their health and seek out preventive measures. Furthermore, the expansion of the healthcare sector in Zambia has created opportunities for the Pharmacy Usual Items market. The government has been investing in healthcare infrastructure and implementing policies to improve access to healthcare services, which has resulted in an increase in the number of healthcare facilities and pharmacies across the country.

Underlying macroeconomic factors:
The growth of the Pharmacy Usual Items market in Zambia can also be attributed to favorable macroeconomic factors. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income and consumer spending. This has allowed consumers to allocate a larger portion of their budget towards healthcare and wellness products. Additionally, the government has implemented policies to promote the development of the pharmaceutical industry in Zambia. This includes providing incentives for local production of pharmaceutical products and reducing import tariffs on essential medications. These measures have contributed to the growth of the Pharmacy Usual Items market by making medications more affordable and accessible to the general population. In conclusion, the Pharmacy Usual Items market in Zambia is experiencing growth due to changing customer preferences, increased accessibility to healthcare services, and favorable macroeconomic factors. The demand for over-the-counter medications and health products is expected to continue to rise as consumers become more health-conscious and the healthcare sector expands further.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)